Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT06138613 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 705
Last updated 2026-04-16
Summary
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
Conditions
Interventions
- DRUG
-
Oral Capsule
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-27
- Primary Completion
- 2027-09-30
- Completion
- 2027-12-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3
-
The Prevention and Treatment of Nausea Associated With Motion Sickness
NCT03986905 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT05548270 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
NCT02155309 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Levo Phencynonate Hydrochloride for the Prevention of Seasickness
NCT02241629 ·Status: COMPLETED ·Phase: PHASE2
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
NCT04272255 ·Status: UNKNOWN ·Phase: PHASE3
-
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
NCT04219982 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness
NCT01198106 ·Status: UNKNOWN ·Phase: NA
-
A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
NCT02839135 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
NCT03920644 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
NCT02500732 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
NCT00641797 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea
NCT00685607 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05886660 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
NCT03755596 ·Status: COMPLETED ·Phase: PHASE4
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Motion Sickness on Astrolabe's Vessel
NCT02911402 ·Status: COMPLETED
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
NCT03833999 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
NCT01578265 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-105 in Healthy Adults
NCT04964258 ·Status: COMPLETED ·Phase: PHASE1